Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

• Main Authors: Mareque M (Author), Montesinos P (Author), Font P (Author), Guinea JM (Author), de la Fuente A (Author), Soto J (Author), Oyagüez I (Author), Brockbank J (Author), Iglesias T (Author), Llinares J (Author), Sierra J (Author)
• Format: Book
• Published: Dove Medical Press, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Maria Mareque,1 Pau Montesinos,2 Patricia Font,3 José María Guinea,4 Adolfo de la Fuente,5 Javier Soto,6 Itziar Oyagüez,1 James Brockbank,7 Tamara Iglesias,6 Julia Llinares,6 Jorge Sierra8 1Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain; 2Hospital Universitario La Fe, Valenc...